Goldline Pharma. Stock Price Analysis and Quick Research Report. Is Goldline Pharma. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Goldline Pharma.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Goldline Pharma. has a PE ratio of 10.0265759045132 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Goldline Pharma. has ROA of 11.5177% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Goldline Pharma. has a Current ratio of 1.9847.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Goldline Pharma. has a ROE of 38.8119%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Goldline Pharma. has a Debt to Equity ratio of 1.0658 which means that the company has low proportion of debt in its capital.

• Sales growth: Goldline Pharma. has reported revenue growth of 19.0516% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Goldline Pharma. for the current financial year is 21.5852750065049%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Goldline Pharma. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Goldline Pharma. is Rs 4.2896. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Goldline Pharma. in Ticker for free. Also, one can get the intrinsic value of Goldline Pharma. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Goldline Pharma. FAQs

Q1. What is Goldline Pharma. share price today?
Ans: The current share price of Goldline Pharma. is Rs 43.01.

Q2. What is the market capitalisation of Goldline Pharma.?
Ans: Goldline Pharma. has a market capitalisation of Rs 41.2896 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Goldline Pharma.?
Ans: The PE ratio of Goldline Pharma. is 10.0265759045132 and the P/B ratio of Goldline Pharma. is 2.04846591287947, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Goldline Pharma. share?
Ans: The 52-week high share price of Goldline Pharma. is Rs 60, and the 52-week low share price of Goldline Pharma. is Rs 41.41.

Q5. Does Goldline Pharma. pay dividends?
Ans: Currently, Goldline Pharma. does not pay dividends. Dividend yield of Goldline Pharma. is around 0%.

Q6. What are the face value and book value of Goldline Pharma. shares?
Ans: The face value of Goldline Pharma. shares is Rs 10, while the book value per share of Goldline Pharma. is around Rs 20.9962. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Goldline Pharma.?
Ans: Goldline Pharma. has a total debt of Rs 11.0344 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Goldline Pharma.?
Ans: The ROE of Goldline Pharma. is 38.8119% and ROCE of Goldline Pharma. is 28.7525%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Goldline Pharma. a good buy for the long term?
Ans: The Goldline Pharma. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Goldline Pharma. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Goldline Pharma. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Goldline Pharma.’s financials?
Ans: You can review Goldline Pharma.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.